Publisher: Bentham Science Publishers
E-ISSN: 1875-533x|25|4|462-477
ISSN: 0929-8673
Source: Current Medicinal Chemistry, Vol.25, Iss.4, 2018-02, pp. : 462-477
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Docetaxel + cisplatin active in advanced NSCLC
Inpharma, Vol. 1, Iss. 1478, 2005-01 ,pp. :
Computational Models for Predicting Interactions with Membrane Transporters
Current Medicinal Chemistry, Vol. 20, Iss. 16, 2013-05 ,pp. :
S-1 + cisplatin promising for advanced NSCLC
Inpharma, Vol. 1, Iss. 1475, 2005-01 ,pp. :
Cisplatin + pemetrexed as first-line therapy for advanced NSCLC
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 593, 2009-01 ,pp. :